Dr Francesca Panin


Faculty:Faculty of Health, Education, Medicine and Social Care

School:Allied Health

Location: Cambridge

Areas of Expertise: Cardiology , Neuroscience , Health and social care

Francesca Panin is an experienced researcher in neuroscience and cardiology, and a pharmacist with a PhD in neuroscience. Her areas of expertise include pharmacology, neuroscience, cardiology and regulatory/ethics skills for pre-clinical and clinical research. At ARU, Francesca trains students on research methods and Undergraduate Major Project.

Email: francesca.panin@anglia.ac.uk

LinkedIn: Francesca Panin


Francesca is a pharmacist registered with the local GPhC who's worked for ten years in medical research.

She obtained a PhD in neuroscience in Italy, and pursued her research career by working as postdoctoral researcher at the centre for health and medical research INSERM in Bordeaux (France). She subsequently obtained a certificate to work as a Clinical Research Associate in Bordeaux, where she managed clinical trials on electric and pharmacologic therapies for cardiac failures in the hospital. She recently managed a clinical study on metabolic and sleep disturbances in Huntington’s Disease, at the Cambridge University Hospital. She is currently setting up research activity on Electro-EncephaloGrams (EEGs).

Research interests

  • The neural mechanisms underlying the switch from depression to mania in bipolar patients
  • The neural mechanisms underlying the development of drug addiction
  • The development of new therapies to treat cardiac failures: pharmacology and medical devices
  • The use of polysomnography to diagnose and treat sleep disturbances
  • The use of EEG to study the neural mechanisms regulating the gait activity

Areas of research supervision

  • Supervision of Pharmacy postgraduate students (neural mechanisms of depression)
  • Second supervisor for 1 PhD student on the neural mechanisms of drug addiction
  • Supervision of trainee clinical research assistants on the management of the tele-cardiology
  • Pharmaceutical chemistry and technology (postgraduate degree), Faculty of Pharmacy, University of Sassari (Italy)
  • Pharmacist qualification, Pharmacy, Ministry of Health, Sassari (Italy)
  • PhD Neuroscience, Faculty of Medicine, University of Sassari (Italy)
  • Certificate of aptitude to work as Clinical Research Assistant, ISVM Bordeaux (France)
  • Good Clinical Practice certificate, online training, Epigeum
  • Motor Rater certificate to diagnose motor impairments in Huntington’s Disease, EuroHD (online training)
  • IELTS certificate (7.5 overall score), Anglia Ruskin University

Memberships, editorial boards

  • General Pharmaceutical Council, UK
  • ARU Society for Healthcare Science

Recent presentations and conferences

Collins L.M., Begeti F., Panin F., Lazar A.S., Cruickshank T., Ziman M., Mason S.L., Barker R.A., 2015. Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington's Disease. PLoS Current, PMCID: PMC4570842.

Panin F.*, Lazar A.S.*, Goodman A.O., Lazic S.E., Lazar Z.I., Mason S.L., Rogers L., Murgatroyd P.R., Watson L.P., Singh P., Borowsky B., Shneerson J.M., Barker R.A., 2015. Sleep deficits but no metabolic deficits in premanifest Huntington's disease. Annals of Neurology, 78(4):630-48.
*=equal contribution

Panin, F., Lintas, A., Diana, M., 2014. Nicotine-induced increase of dopaminergic mesoaccumbal neuron activity is prevented by acute restraint stress. In vivo electrophysiology in rats. Eur Neuropsychopharmacology, 24, pp 1175-1180.

Vallée, M., Vitiello, S., Bellocchio, L., Hébert-Chatelain, E., Monlezun, S., Martin-Garcia, E., Kasanetz, F., Baillie, G.L., Panin, F., Cathala, A., Roullot-Lacarrière, V., Fabre, S., Hurst, D.P., Lynch, D.L., Shore, D.M., Deroche-Gamonet, V., Spampinato, U., Revest, J.M., Maldonado, R., Reggio, P.H., Ross, R.A., Marsicano, G., Piazza, P.V., 2014. Pregnenolone can protect the brain from cannabis intoxication. Science, 343, pp 94-98.

Panin, F., Cathala, A., Piazza, P.V., Spampinato, U., 2012. Coupled intracerebral microdialysis and electrophysiology for the assessment of dopamine neuron function in vivo. Journal of Pharmacological and Toxicological Methods, 65, pp 83-92.